J
Joanna Dukes-McEwan
Researcher at University of Liverpool
Publications - 89
Citations - 2709
Joanna Dukes-McEwan is an academic researcher from University of Liverpool. The author has contributed to research in topics: Heart failure & Population. The author has an hindex of 27, co-authored 89 publications receiving 2366 citations. Previous affiliations of Joanna Dukes-McEwan include Royal Veterinary College & University of Glasgow.
Papers
More filters
Journal ArticleDOI
Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study.
Jens Häggström,Adrian Boswood,Michael R. O'Grady,Olaf Jöns,Sarah Smith,Simon Swift,M. Borgarelli,B. Gavaghan,Jan-Gerd Kresken,M. Patteson,B. Åblad,Claudio Bussadori,Tony M. Glaus,A. Kovacevic,M. Rapp,Roberto A. Santilli,Anna Tidholm,A. Eriksson,M.C. Belanger,M. Deinert,C.J.L. Little,Clarence Kvart,Anne French,M. Ronn-Landbo,Gerhard Wess,A.V. Eggertsdottir,M.L. O'Sullivan,Matthias Schneider,Christophe W. Lombard,Joanna Dukes-McEwan,Ruth Willis,A. Louvet,Rocky DiFruscia +32 more
TL;DR: Pimobendan plus conventional therapy prolongs time to sudden death, euthanasia for cardiac reasons, or treatment failure in dogs with CHF caused by MMVD compared with benazeprilplus conventional therapy.
Journal ArticleDOI
Proposed guidelines for the diagnosis of canine idiopathic dilated cardiomyopathy.
TL;DR: A scoring system for the identification of dogs in the pre-clinical stages of DCM, predominantly based on 2D and M-mode echocardiography is proposed, which includes a number of major criteria and minor criteria.
Journal ArticleDOI
Efficacy of Pimobendan in the prevention of congestive heart failure or sudden death in Doberman Pinschers with preclinical dilated cardiomyopathy (The PROTECT Study)
Nuala Summerfield,Adrian Boswood,Michael R. O'Grady,Sonya G. Gordon,Joanna Dukes-McEwan,Mark A. Oyama,Sarah Smith,M. Patteson,Anne French,Geoff Culshaw,L Braz-Ruivo,Amara H. Estrada,M. L. O'Sullivan,J. Loureiro,Ruth Willis,P. Watson +15 more
TL;DR: Administration of pimobendan to Dobermans with preclinical DCM prolongs the time to the onset of clinical signs and extends survival and treatment of dogs in the preclinical phase of this common cardiovascular disorder can lead to improved outcome.
Journal ArticleDOI
The diagnostic accuracy of different natriuretic peptides in the investigation of canine cardiac disease
Adrian Boswood,Joanna Dukes-McEwan,J. Loureiro,R. A. James,M. Martin,M. Stafford-Johnson,P. Smith,C. Little,S. Attree +8 more
TL;DR: Canine NT-proBNP appears to be a useful marker of the presence of cardiac disease, although concentrations must be interpreted in the light of the patient's renal function.
Journal ArticleDOI
Cardiac troponin I as a marker for severity and prognosis of cardiac disease in dogs.
TL;DR: It was concluded that cTnI is useful in assessing the prognosis and severity of cardiac diseases in dogs, and progression and response to treatment can be assessed by repeat sampling.